Eplus (PLUS) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q1 FY2027, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PLUS SEC filings page.
Eplus (PLUS) reported $2.4B in revenue for fiscal year 2026, up 22.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue acceleration is translating into operating-margin recovery, while working-capital swings make reported earnings an unreliable guide to annual cash generation.
Revenue reached$2.4B , and operating income recovered to$166M . Yet operating cash flow swung to-$116M from$302M in the prior year, a cash-conversion reversal despite the earnings rebound. The mismatch aligns with working-capital absorption: receivables and inventory both increased, so accounting profit did not arrive as cash.
Gross margin remained broadly stable, but operating margin recovered from
The current ratio improved from 1.7x to 2.2x even as operating cash flow turned negative, showing short-term liquidity did not move in lockstep with cash generation. Total liabilities fell to
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Eplus's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Eplus has an operating margin of 6.8%, meaning the company retains $7 of operating profit per $100 of revenue. This results in a moderate score of 63/100, indicating healthy but not exceptional operating efficiency. This is up from 5.0% the prior year.
Eplus's revenue surged 22.1% year-over-year to $2.4B, reflecting rapid business expansion. This strong growth earns a score of 53/100.
Eplus has a moderate D/E ratio of 0.68. This balance of debt and equity financing earns a leverage score of 55/100.
With a current ratio of 2.24, Eplus holds $2.24 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 65/100.
Eplus's operations used $116.2M of cash, and capex of $4.4M added to the outflow, for a free cash flow shortfall of $120.7M. This results in a cash flow score of 41/100.
Eplus earns a strong 12.4% return on equity (ROE), meaning it generates $12 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 75/100. This is up from 10.8% the prior year.
Eplus scores 4.80, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Eplus passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Eplus used $0.88 of operating cash (-$116.2M OCF vs $132.6M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Key Financial Metrics
Earnings & Revenue
Eplus generated $649.1M in revenue in Q1 2027. This represents an increase of 1.0% from the same quarter a year earlier. Against the prior quarter it is up 12.7%.
Eplus's EBITDA was $45.0M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 10.6% from the same quarter a year earlier. Against the prior quarter it is up 19.0%.
Eplus reported $30.3M in net income in Q1 2027. This represents a decrease of 28.9% from the same quarter a year earlier. Against the prior quarter it is up 50.3%.
Eplus earned $1.16 per diluted share (EPS) in Q1 2027. This represents a decrease of 28.0% from the same quarter a year earlier. Against the prior quarter it is up 22.1%.
Cash & Balance Sheet
Eplus generated $75.6M in free cash flow in Q1 2027, representing cash available after capex. This represents an increase of 175.8% from the same quarter a year earlier. Against the prior quarter it is down 27.1%.
Eplus held $448.9M in cash as of Q1 2027; long-term debt is not reported for that period.
Eplus paid $0.27 per share in dividends in Q1 2027.
Margins & Returns
Eplus's gross margin was 23.3% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is down 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.3 percentage points.
Eplus's operating margin was 6.0% in Q1 2027, reflecting core business profitability. This is down 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.
Eplus's net profit margin was 4.7% in Q1 2027, showing the share of revenue converted to profit. This is down 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.2 percentage points.
Eplus's ROE was 2.8% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is down 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.
Capital Allocation
Eplus spent $25.5M on share buybacks in Q1 2027, returning capital to shareholders by reducing shares outstanding. This represents an increase of 670.6% from the same quarter a year earlier. Against the prior quarter it is up 303.3%.
Eplus invested $853K in capex in Q1 2027, funding long-term assets and infrastructure. This represents an increase of 2.2% from the same quarter a year earlier. Against the prior quarter it is down 27.7%.
Not reported for Q1 2027.
PLUS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $649.1M+1.0% | $576.2M+20.6% | $614.8M+24.6% | $608.8M+23.4% | $642.8M+20.0% | $477.9M-5.8% | $493.2M-3.1% | $493.4M-16.0% |
| Cost of Revenue | $497.8M+1.8% | $434.5M+25.9% | $456.1M+23.9% | $446.7M+22.0% | $489.1M+19.6% | $345.1M-17.1% | $368.1M-1.9% | $366.1M-17.4% |
| Gross Profit | $151.3M-1.5% | $141.6M+6.6% | $158.7M+26.8% | $162.1M+27.4% | $153.7M+21.1% | $132.9M+45.5% | $125.1M-6.5% | $127.3M-11.8% |
| SG&A Expenses | $106.6M+2.8% | $104.6M+3.9% | $108.7M+7.7% | $106.5M+12.6% | $103.7M+14.4% | $100.6M+20.9% | $100.9M+12.9% | $94.5M+2.0% |
| Operating Income | $38.8M-9.6% | $30.9M+24.8% | $43.5M+163.9% | $48.8M+80.9% | $42.9M+36.5% | $24.8M+442.5% | $16.5M-56.7% | $27.0M-39.8% |
| EBITDA | $45.0M-10.6% | $37.8M+13.5% | $50.0M+106.9% | $55.6M+69.9% | $50.4M+37.3% | $33.3M+223.9% | $24.1M-44.4% | $32.8M-35.1% |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | $572K-20.9% | $517K-47.4% | $537K-56.0% |
| Income Tax | $11.7M+1.3% | $9.8M+24.3% | $12.2M+127.8% | $15.8M+110.8% | $11.5M+28.5% | $7.8M+338.5% | $5.4M-51.9% | $7.5M-39.0% |
| Net Income | $30.3M-28.9% | $20.1M-7.6% | $35.1M+45.2% | $34.9M+11.3% | $42.6M+55.8% | $21.8M-9.9% | $24.1M-11.5% | $31.3M-4.1% |
| EPS (Basic) | $1.17-27.8% | $0.950.0% | $1.34+47.3% | $1.32+11.9% | $1.62+57.3% | $0.95+15.9% | $0.91-10.8% | $1.18-4.1% |
| EPS (Diluted) | $1.16-28.0% | $0.950.0% | $1.33+46.2% | $1.32+12.8% | $1.61+57.8% | $0.95+17.3% | $0.91-10.8% | $1.17-4.1% |
| Diluted Shares (Avg) | 26M-1.2% | N/A | 26M-1.2% | 26M-1.0% | 26M-1.6% | N/A | 27M-0.3% | 27M0.0% |
Not reported in any period shown, so not listed: R&D Expenses.
PLUS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.9B+3.8% | $1.8B-4.2% | $1.8B+3.7% | $1.8B+3.9% | $1.8B+9.0% | $1.9B+13.6% | $1.8B+10.7% | $1.7B+5.0% |
| Current Assets | $1.5B+7.0% | $1.4B+5.1% | $1.5B+13.9% | $1.4B+14.2% | $1.4B+10.9% | $1.4B+6.6% | $1.3B+4.7% | $1.2B-5.3% |
| Cash & Equivalents | $448.9M-6.5% | $410.8M+5.5% | $326.3M+28.9% | $402.2M+114.5% | $480.2M+37.2% | $389.4M+53.9% | $253.1M+78.0% | $187.5M+127.3% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $146.0M+44.4% | $200.9M+66.8% | $241.0M+143.4% | $154.1M+64.2% | $101.1M+13.4% | $120.4M-13.8% | $99.0M-54.6% | $93.9M-57.7% |
| Accounts Receivable | $746.0M+6.4% | $650.0M+27.9% | $698.0M+17.5% | $676.8M+15.1% | $700.9M+21.5% | $508.3M-21.1% | $594.2M-0.5% | $588.0M-9.5% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $202.9M0.0% | $202.9M0.0% | $202.9M+0.1% | $202.9M-0.2% | $203.0M+25.7% | $202.9M+25.6% | $202.8M+28.1% | $203.2M+28.5% |
| Total Liabilities | $795.0M+2.1% | $732.0M-19.4% | $768.4M-4.4% | $720.7M-4.3% | $778.7M+6.8% | $908.4M+20.9% | $803.4M+11.9% | $753.1M-2.6% |
| Current Liabilities | $704.3M+2.4% | $638.1M-20.1% | $682.1M-2.1% | $628.1M-3.4% | $687.8M+9.5% | $799.1M+21.6% | $696.8M+10.3% | $649.9M-7.2% |
| Non-Current Liabilities | $90.7M-0.2% | $93.8M-14.1% | $86.3M-19.1% | $92.6M-10.2% | $91.0M-9.8% | $109.3M+15.4% | $106.6M+23.4% | $103.1M+41.8% |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | $38.8M | N/A | N/A |
| Total Equity | $1.1B+5.4% | $1.1B+10.1% | $1.1B+10.5% | $1.0B+10.5% | $1.0B+10.4% | $970.7M+8.2% | $962.3M+9.6% | $947.0M+12.0% |
| Retained Earnings | $979.2M+10.2% | $956.0M+13.4% | $945.3M+14.5% | $916.9M+14.4% | $888.7M+15.4% | $843.2M+13.5% | $825.8M+14.5% | $801.6M+15.6% |
PLUS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $76.5M+177.3% | $105.0M-34.8% | -$87.4M-233.1% | -$34.8M-60.8% | -$99.0M-201.9% | $160.9M+53.3% | $65.7M-50.7% | -$21.6M-169.2% |
| Depreciation & Amortization | $6.2M-16.9% | $6.4M-18.0% | $6.5M-15.4% | $6.8M+18.1% | $7.4M+42.3% | $7.8M+166.7% | $7.7M+42.2% | $5.8M+2.4% |
| Stock-Based Compensation | $3.1M+17.2% | N/A | $3.4M+19.6% | $3.1M+20.9% | $2.7M-4.6% | N/A | $2.9M+13.3% | $2.5M+4.8% |
| Capital Expenditures | $853K+2.2% | $1.2M-36.5% | N/A | N/A | $835K | $1.9M | N/A | N/A |
| Free Cash Flow | $75.6M+175.8% | $103.8M-34.8% | N/A | N/A | -$99.8M | $159.1M | N/A | N/A |
| Investing Cash Flow | -$853K-100.5% | $6.3M+507.5% | -$1.4M-421.1% | -$989K+99.2% | $155.9M+8277.2% | -$1.6M+74.6% | $432K+121.6% | -$125.8M-1458.5% |
| Financing Cash Flow | -$37.8M-218.5% | -$26.3M-8.9% | $13.0M+1434.4% | -$41.5M-161.4% | $31.9M+1880.4% | -$24.1M-300.7% | $845K+101.2% | -$15.9M+73.5% |
| Dividends Paid | $7.1M | $6.5M | $6.5M | $6.6M | $0 | $0 | $0 | N/A |
| Share Buybacks | $25.5M+670.6% | $6.3M-53.2% | $17.0M+71.2% | $4.0M-66.2% | $3.3M-71.4% | $13.5M+36327.0% | $9.9M+576.8% | $12.0M+1250.8% |
PLUS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 23.3%-0.6pp | 24.6%-3.2pp | 25.8%+0.5pp | 26.6%+0.8pp | 23.9%+0.2pp | 27.8%+9.8pp | 25.4%-0.9pp | 25.8%+1.2pp |
| Operating Margin | 6.0%-0.7pp | 5.4%+0.2pp | 7.1%+3.7pp | 8.0%+2.5pp | 6.7%+0.8pp | 5.2%+4.3pp | 3.3%-4.1pp | 5.5%-2.2pp |
| Net Margin | 4.7%-2.0pp | 3.5%-1.1pp | 5.7%+0.8pp | 5.7%-0.6pp | 6.6%+1.5pp | 4.6%-0.2pp | 4.9%-0.5pp | 6.3%+0.8pp |
| Return on Equity | 2.8%-1.4pp | 1.9%-0.4pp | 3.3%+0.8pp | 3.3%0.0pp | 4.2%+1.2pp | 2.3%-0.5pp | 2.5%-0.6pp | 3.3%-0.6pp |
| Return on Assets | 1.6%-0.8pp | 1.1%0.0pp | 1.9%+0.5pp | 2.0%+0.1pp | 2.4%+0.7pp | 1.2%-0.3pp | 1.4%-0.3pp | 1.8%-0.2pp |
| Current Ratio | 2.13+0.1x | 2.24+0.5x | 2.13+0.3x | 2.19+0.3x | 2.040.0x | 1.70-0.2x | 1.83-0.1x | 1.850.0x |
| Debt-to-Equity | 0.740.0x | 0.68+0.6x | 0.72-0.1x | 0.69-0.1x | 0.770.0x | 0.04-0.8x | 0.830.0x | 0.80-0.1x |
| Asset Turnover | 0.350.0x | 0.32+0.1x | 0.34+0.1x | 0.34+0.1x | 0.360.0x | 0.25-0.1x | 0.280.0x | 0.29-0.1x |
| FCF Margin | 11.7%+27.2pp | 18.0%-15.3pp | N/A | N/A | -15.5% | 33.3% | N/A | N/A |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Eplus PLUS | FY2026 | $2.4B | $132.6M | 5.4% | $2.3B | 59/100 |
| Par Technology PAR | FY2025 | $455.5M | -$84.5M | -18.5% | $777.6M | 47/100 |
| Sprinklr Inc CXM | FY2026 | $857.2M | $22.9M | 2.7% | $1.9B | 50/100 |
| Porch Group Inc PRCH | FY2025 | $482.4M | -$3.4M | -0.7% | $1.9B | 41/100 |
| Amplitude Inc AMPL | FY2025 | $343.2M | -$88.5M | -25.8% | $1.8B | 37/100 |
Where Eplus Ranks
Frequently Asked Questions
What is Eplus's annual revenue?
Eplus (PLUS) reported $2.4B in total revenue for fiscal year 2026. This represents a 22.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Eplus's revenue growing?
Eplus (PLUS) revenue grew by 22.1% year-over-year, from $2.0B to $2.4B in fiscal year 2026.
Is Eplus profitable?
Yes, Eplus (PLUS) reported a net income of $132.6M in fiscal year 2026, with a net profit margin of 5.4%.
What is Eplus's EBITDA?
Eplus (PLUS) had EBITDA of $193.8M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Eplus's gross margin?
Eplus (PLUS) had a gross margin of 25.2% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Eplus's operating margin?
Eplus (PLUS) had an operating margin of 6.8% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Eplus's net profit margin?
Eplus (PLUS) had a net profit margin of 5.4% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
Does Eplus pay dividends?
Yes, Eplus (PLUS) paid $0.75 per share in dividends during fiscal year 2026.
What is Eplus's return on equity (ROE)?
Eplus (PLUS) has a return on equity of 12.4% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Eplus's free cash flow?
Eplus (PLUS) recorded an outflow of $120.7M in free cash flow during fiscal year 2026. This represents a -140.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Eplus's operating cash flow?
Eplus (PLUS) recorded an outflow of $116.2M in operating cash flow during fiscal year 2026, representing cash used by core business activities.
What are Eplus's total assets?
Eplus (PLUS) had $1.8B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Eplus's capital expenditures?
Eplus (PLUS) invested $4.4M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
What is Eplus's current ratio?
Eplus (PLUS) had a current ratio of 2.24 as of fiscal year 2026, which is generally considered healthy.
What is Eplus's debt-to-equity ratio?
Eplus (PLUS) had a debt-to-equity ratio of 0.68 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Eplus's return on assets (ROA)?
Eplus (PLUS) had a return on assets of 7.4% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Eplus's P/E ratio?
Eplus (PLUS) trades at 18.9x earnings, its market capitalization divided by net income of $120.3M net income, trailing 12 months to June 30, 2026. The market capitalization is $2.3B as of Sep 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Eplus's price-to-sales ratio?
Eplus (PLUS) trades at 0.9x sales, its market capitalization divided by revenue of $2.4B revenue, trailing 12 months to June 30, 2026. The market capitalization is $2.3B as of Sep 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Eplus's liquidity compare with its operating cash outflow?
At the end of fiscal year 2026, Eplus (PLUS) held $410.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $116.2M over that year. Dividing the one by the other, the reported balance equals about 42 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Eplus's Altman Z-Score?
Eplus (PLUS) has an Altman Z-Score of 4.80, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Eplus's Piotroski F-Score?
Eplus (PLUS) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Eplus's earnings high quality?
For every $1 of reported earnings, Eplus (PLUS) used $0.88 of operating cash (-$116.2M OCF vs $132.6M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Eplus?
Eplus (PLUS) scores 59 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.